Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma

Medulloblastoma is one of the most prevalent malignant brain tumors in children and has very poor prognosis. In this study, the authors show, using a mouse model of medulloblastoma, that Gfi1 promotes tumor growth by recruiting Lsd1, that this interaction inhibits genes involved in neuronal differen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Catherine Lee, Vasilisa A. Rudneva, Serap Erkek, Marc Zapatka, Lianne Q. Chau, Silvia K. Tacheva-Grigorova, Alexandra Garancher, Jessica M. Rusert, Ozlem Aksoy, Robin Lea, Helai P. Mohammad, Jianxun Wang, William A. Weiss, H. Leighton Grimes, Stefan M. Pfister, Paul A. Northcott, Robert J. Wechsler-Reya
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/3008cdc8884c4e79a131516d3e5463b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3008cdc8884c4e79a131516d3e5463b0
record_format dspace
spelling oai:doaj.org-article:3008cdc8884c4e79a131516d3e5463b02021-12-02T16:58:18ZLsd1 as a therapeutic target in Gfi1-activated medulloblastoma10.1038/s41467-018-08269-52041-1723https://doaj.org/article/3008cdc8884c4e79a131516d3e5463b02019-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-08269-5https://doaj.org/toc/2041-1723Medulloblastoma is one of the most prevalent malignant brain tumors in children and has very poor prognosis. In this study, the authors show, using a mouse model of medulloblastoma, that Gfi1 promotes tumor growth by recruiting Lsd1, that this interaction inhibits genes involved in neuronal differentiation, and that Lsd1 may be a therapeutic target in Gfi1-activated tumors.Catherine LeeVasilisa A. RudnevaSerap ErkekMarc ZapatkaLianne Q. ChauSilvia K. Tacheva-GrigorovaAlexandra GarancherJessica M. RusertOzlem AksoyRobin LeaHelai P. MohammadJianxun WangWilliam A. WeissH. Leighton GrimesStefan M. PfisterPaul A. NorthcottRobert J. Wechsler-ReyaNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-13 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Catherine Lee
Vasilisa A. Rudneva
Serap Erkek
Marc Zapatka
Lianne Q. Chau
Silvia K. Tacheva-Grigorova
Alexandra Garancher
Jessica M. Rusert
Ozlem Aksoy
Robin Lea
Helai P. Mohammad
Jianxun Wang
William A. Weiss
H. Leighton Grimes
Stefan M. Pfister
Paul A. Northcott
Robert J. Wechsler-Reya
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
description Medulloblastoma is one of the most prevalent malignant brain tumors in children and has very poor prognosis. In this study, the authors show, using a mouse model of medulloblastoma, that Gfi1 promotes tumor growth by recruiting Lsd1, that this interaction inhibits genes involved in neuronal differentiation, and that Lsd1 may be a therapeutic target in Gfi1-activated tumors.
format article
author Catherine Lee
Vasilisa A. Rudneva
Serap Erkek
Marc Zapatka
Lianne Q. Chau
Silvia K. Tacheva-Grigorova
Alexandra Garancher
Jessica M. Rusert
Ozlem Aksoy
Robin Lea
Helai P. Mohammad
Jianxun Wang
William A. Weiss
H. Leighton Grimes
Stefan M. Pfister
Paul A. Northcott
Robert J. Wechsler-Reya
author_facet Catherine Lee
Vasilisa A. Rudneva
Serap Erkek
Marc Zapatka
Lianne Q. Chau
Silvia K. Tacheva-Grigorova
Alexandra Garancher
Jessica M. Rusert
Ozlem Aksoy
Robin Lea
Helai P. Mohammad
Jianxun Wang
William A. Weiss
H. Leighton Grimes
Stefan M. Pfister
Paul A. Northcott
Robert J. Wechsler-Reya
author_sort Catherine Lee
title Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
title_short Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
title_full Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
title_fullStr Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
title_full_unstemmed Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
title_sort lsd1 as a therapeutic target in gfi1-activated medulloblastoma
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/3008cdc8884c4e79a131516d3e5463b0
work_keys_str_mv AT catherinelee lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT vasilisaarudneva lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT seraperkek lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT marczapatka lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT lianneqchau lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT silviaktachevagrigorova lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT alexandragarancher lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT jessicamrusert lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT ozlemaksoy lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT robinlea lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT helaipmohammad lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT jianxunwang lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT williamaweiss lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT hleightongrimes lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT stefanmpfister lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT paulanorthcott lsd1asatherapeutictargetingfi1activatedmedulloblastoma
AT robertjwechslerreya lsd1asatherapeutictargetingfi1activatedmedulloblastoma
_version_ 1718382318744240128